139 related articles for article (PubMed ID: 16046171)
1. Pathophysiology of disk-related low back pain and sciatica. II. Evidence supporting treatment with TNF-alpha antagonists.
Mulleman D; Mammou S; Griffoul I; Watier H; Goupille P
Joint Bone Spine; 2006 May; 73(3):270-7. PubMed ID: 16046171
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of disk-related sciatica. I.--Evidence supporting a chemical component.
Mulleman D; Mammou S; Griffoul I; Watier H; Goupille P
Joint Bone Spine; 2006 Mar; 73(2):151-8. PubMed ID: 16046173
[TBL] [Abstract][Full Text] [Related]
3. The treatment of disc-herniation-induced sciatica with infliximab: one-year follow-up results of FIRST II, a randomized controlled trial.
Korhonen T; Karppinen J; Paimela L; Malmivaara A; Lindgren KA; Bowman C; Hammond A; Kirkham B; Järvinen S; Niinimäki J; Veeger N; Haapea M; Torkki M; Tervonen O; Seitsalo S; Hurri H
Spine (Phila Pa 1976); 2006 Nov; 31(24):2759-66. PubMed ID: 17108825
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of tumor necrosis factor-alpha prevents nucleus pulposus-induced thrombus formation, intraneural edema, and reduction of nerve conduction velocity: possible implications for future pharmacologic treatment strategies of sciatica.
Olmarker K; Rydevik B
Spine (Phila Pa 1976); 2001 Apr; 26(8):863-9. PubMed ID: 11317106
[TBL] [Abstract][Full Text] [Related]
5. The treatment of disc herniation-induced sciatica with infliximab: results of a randomized, controlled, 3-month follow-up study.
Korhonen T; Karppinen J; Paimela L; Malmivaara A; Lindgren KA; Järvinen S; Niinimäki J; Veeger N; Seitsalo S; Hurri H
Spine (Phila Pa 1976); 2005 Dec; 30(24):2724-8. PubMed ID: 16371894
[TBL] [Abstract][Full Text] [Related]
6. [New information concerning pain caused by herniated disk and sciatica. Exposure to disk tissue sensitizes the nerve roots].
Olmarker K; Rydevik B
Lakartidningen; 1998 Dec; 95(49):5618-22. PubMed ID: 9863299
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-alpha monoclonal antibody, infliximab, used to manage severe sciatica.
Karppinen J; Korhonen T; Malmivaara A; Paimela L; Kyllönen E; Lindgren KA; Rantanen P; Tervonen O; Niinimäki J; Seitsalo S; Hurri H
Spine (Phila Pa 1976); 2003 Apr; 28(8):750-3; discussion 753-4. PubMed ID: 12698115
[TBL] [Abstract][Full Text] [Related]
8. Dorsal root sensitivity to interleukin-1 beta, interleukin-6 and tumor necrosis factor in rats.
Ozaktay AC; Cavanaugh JM; Asik I; DeLeo JA; Weinstein JN
Eur Spine J; 2002 Oct; 11(5):467-75. PubMed ID: 12384756
[TBL] [Abstract][Full Text] [Related]
9. 2000 Volvo Award winner in basic science studies: Exogenous tumor necrosis factor-alpha mimics nucleus pulposus-induced neuropathology. Molecular, histologic, and behavioral comparisons in rats.
Igarashi T; Kikuchi S; Shubayev V; Myers RR
Spine (Phila Pa 1976); 2000 Dec; 25(23):2975-80. PubMed ID: 11145807
[TBL] [Abstract][Full Text] [Related]
10. [Sciatica and herniated disk. Current aspects of pathophysiology and pain mechanisms].
Rydevik B
Nord Med; 1994; 109(3):74-6, 80. PubMed ID: 8139899
[TBL] [Abstract][Full Text] [Related]
11. Infliximab attenuates immunoreactivity of brain-derived neurotrophic factor in a rat model of herniated nucleus pulposus.
Onda A; Murata Y; Rydevik B; Larsson K; Kikuchi S; Olmarker K
Spine (Phila Pa 1976); 2004 Sep; 29(17):1857-61. PubMed ID: 15534405
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis alpha-blocking agent (etanercept): a triple blind randomized controlled trial of its use in treatment of sciatica.
Okoro T; Tafazal SI; Longworth S; Sell PJ
J Spinal Disord Tech; 2010 Feb; 23(1):74-7. PubMed ID: 20072036
[TBL] [Abstract][Full Text] [Related]
13. Epidural administration of spinal nerves with the tumor necrosis factor-alpha inhibitor, etanercept, compared with dexamethasone for treatment of sciatica in patients with lumbar spinal stenosis: a prospective randomized study.
Ohtori S; Miyagi M; Eguchi Y; Inoue G; Orita S; Ochiai N; Kishida S; Kuniyoshi K; Nakamura J; Aoki Y; Ishikawa T; Arai G; Kamoda H; Suzuki M; Takaso M; Furuya T; Toyone T; Takahashi K
Spine (Phila Pa 1976); 2012 Mar; 37(6):439-44. PubMed ID: 22020607
[TBL] [Abstract][Full Text] [Related]
14. Prevention of compartment syndrome in dorsal root ganglia caused by exposure to nucleus pulposus.
Yabuki S; Onda A; Kikuchi S; Myers RR
Spine (Phila Pa 1976); 2001 Apr; 26(8):870-5. PubMed ID: 11317107
[TBL] [Abstract][Full Text] [Related]
15. [Back pain. Experimental studies are successful].
Olmarker K
Nord Med; 1998 Sep; 113(7):235-6. PubMed ID: 9755621
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of tumor necrosis factor-alpha blockade for severe sciatica?].
Genevay S; Guerne PA; Gabay C
Rev Med Suisse Romande; 2004 Sep; 124(9):543-5. PubMed ID: 15552747
[TBL] [Abstract][Full Text] [Related]
17. Participation of 5-hydroxytryptamine in pain-related behavior induced by nucleus pulposus applied on the nerve root in rats.
Kato K; Kikuchi S; Konno S; Sekiguchi M
Spine (Phila Pa 1976); 2008 May; 33(12):1330-6. PubMed ID: 18496345
[TBL] [Abstract][Full Text] [Related]
18. Biologic Drugs as Analgesics for the Management of Low Back Pain and Sciatica.
Dimitroulas T; Lambe T; Raphael JH; Kitas GD; Duarte RV
Pain Med; 2019 Sep; 20(9):1678-1686. PubMed ID: 30576566
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of infliximab for disc herniation-induced sciatica: one-year follow-up.
Korhonen T; Karppinen J; Malmivaara A; Autio R; Niinimäki J; Paimela L; Kyllönen E; Lindgren KA; Tervonen O; Seitsalo S; Hurri H
Spine (Phila Pa 1976); 2004 Oct; 29(19):2115-9. PubMed ID: 15454701
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of tumor necrosis factor-alpha prevents nucleus pulposus-induced histologic changes in the dorsal root ganglion.
Murata Y; Onda A; Rydevik B; Takahashi K; Olmarker K
Spine (Phila Pa 1976); 2004 Nov; 29(22):2477-84. PubMed ID: 15543058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
